Enhancement by transition metals of chromosome aberrations induced by isoniazid.
Whiting
R F
RF
Environmental Carcinogenesis Unit, British Columbia Cancer Research Centre, and Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
Wei
L
L
Stich
H F
HF
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D016466:CHO Cells; D002869:Chromosome Aberrations / Q000187:drug effects*; D006224:Cricetinae; D003412:Cricetulus; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D007538:Isoniazid / Q000494:pharmacology*; D008677:Metaphase / Q000187:drug effects; D028561:Transition Elements / Q000494:pharmacology*
D000995:Antitubercular Agents; D028561:Transition Elements; D007538:Isoniazid